Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Purchased by Credit Suisse AG

Credit Suisse AG raised its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 2.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 44,230 shares of the company’s stock after buying an additional 1,181 shares during the period. Credit Suisse AG owned about 0.09% of Prestige Consumer Healthcare worth $2,770,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. BlackRock Inc. lifted its position in Prestige Consumer Healthcare by 12.4% during the first quarter. BlackRock Inc. now owns 9,115,718 shares of the company’s stock valued at $482,584,000 after buying an additional 1,004,337 shares in the last quarter. Vanguard Group Inc. lifted its position in shares of Prestige Consumer Healthcare by 0.6% during the third quarter. Vanguard Group Inc. now owns 5,647,622 shares of the company’s stock worth $281,421,000 after purchasing an additional 32,646 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Prestige Consumer Healthcare by 3.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,674,930 shares of the company’s stock worth $230,053,000 after purchasing an additional 116,613 shares in the last quarter. Macquarie Group Ltd. lifted its position in shares of Prestige Consumer Healthcare by 2.6% during the fourth quarter. Macquarie Group Ltd. now owns 1,972,000 shares of the company’s stock worth $123,447,000 after purchasing an additional 50,677 shares in the last quarter. Finally, State Street Corp lifted its position in shares of Prestige Consumer Healthcare by 1.2% during the third quarter. State Street Corp now owns 1,944,342 shares of the company’s stock worth $96,887,000 after purchasing an additional 22,886 shares in the last quarter. 99.95% of the stock is owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Trading Up 0.1 %

PBH opened at $58.37 on Friday. The stock has a market capitalization of $2.89 billion, a PE ratio of -34.13, a P/E/G ratio of 1.73 and a beta of 0.58. The firm’s fifty day moving average price is $61.14 and its 200 day moving average price is $60.57. The company has a debt-to-equity ratio of 0.89, a current ratio of 2.66 and a quick ratio of 1.51. Prestige Consumer Healthcare Inc. has a 12-month low of $48.51 and a 12-month high of $68.54.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.05. Prestige Consumer Healthcare had a negative net margin of 7.46% and a positive return on equity of 13.47%. The firm had revenue of $279.31 million for the quarter, compared to analysts’ expectations of $278.79 million. During the same period in the prior year, the company posted $1.09 earnings per share. The firm’s quarterly revenue was up .8% on a year-over-year basis. As a group, research analysts expect that Prestige Consumer Healthcare Inc. will post 4.31 EPS for the current fiscal year.

Insider Buying and Selling at Prestige Consumer Healthcare

In other Prestige Consumer Healthcare news, CEO Ronald M. Lombardi sold 32,800 shares of the business’s stock in a transaction on Tuesday, August 8th. The shares were sold at an average price of $65.57, for a total transaction of $2,150,696.00. Following the completion of the sale, the chief executive officer now owns 270,557 shares in the company, valued at $17,740,422.49. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.60% of the stock is owned by insiders.

Wall Street Analyst Weigh In

PBH has been the topic of a number of recent research reports. StockNews.com initiated coverage on shares of Prestige Consumer Healthcare in a research report on Thursday, August 17th. They set a “buy” rating on the stock. 3M reissued a “reiterates” rating on shares of Prestige Consumer Healthcare in a research report on Monday, June 26th. Finally, TheStreet raised shares of Prestige Consumer Healthcare from a “c+” rating to a “b” rating in a report on Monday, August 7th. One equities research analyst has rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $82.00.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.